COST EFFECTIVENESS OF ADDING EZETIMIBE TO ATORVASTATIN THERAPY IN PATIENTS NOT AT LDL CHOLESTEROL TREATMENT GOAL IN BRAZIL

被引：0
|
作者：
Araujo, G. T. [1 ]
Fonseca, M. [1 ]
Etto, H. [2 ]
Davies, G. M. [3 ]
Hsu, T. Y. [4 ]
机构：
[1] Univ Fed Sao Paulo, Axia Bio Consulting, Sao Paulo, Brazil
[2] Axia Bio, Sao Paulo, Brazil
[3] Merck & Co Inc, Upper Gwynedd, PA USA
[4] Merck Sharp & Dohme Ltd, Whitehouse Stn, NJ USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.999
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A372 / A372
页数：1
相关论文
共 50 条
  • [41] Projected percent LDL-C reduction & NCEP-III cholesterol goal attainment with ezetimibe/simvastatin in a cohort of gubbio patients not at goal on statin monotherapy
    Zanchetti, A.
    Carratelli, L.
    Sampinato, L.
    Maselli, C.
    Alemao, E.
    Davies, G. M.
    Yin, D.
    Cook, J. R.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 198 - 198
  • [42] Ezetimibe added to statin therapy reduces LDL-C and improves goal attainment in patients with diabetes and metabolic syndrome
    Denke, M
    McBride, P
    Pearson, T
    Battisti, WP
    Brady, WE
    Palmisano, J
    [J]. DIABETES, 2004, 53 : A122 - A122
  • [43] The cost-effectiveness of adding infliximab to usual therapy in the treatment of psoriatic arthritis
    Marra, CA
    Maetzel, A
    Farewell, VT
    Rashidi, AA
    Shi, P
    Antoni, C
    Wong, JB
    Gladman, DD
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 242 - 242
  • [44] Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: A substudy of the ezetimibe add-on to statin for effectiveness trial
    Pearson, Thomas A.
    Denke, Margo A.
    McBride, Patrick E.
    Battisti, Wendy P.
    Gazzara, Russell A.
    Brady, William E.
    Palmisano, Joanne
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (09) : 1177 - 1185
  • [45] The cost-effectiveness of adding infliximab to usual therapy in the treatment of psoriatic arthritis
    Marra, CA
    Farewell, V
    Antoni, C
    Rashidi, A
    Maetzel, A
    Kavanaugh, A
    Mease, P
    Wong, JB
    Gladman, DD
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 333 - 333
  • [46] Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe
    Ruel, Isabelle
    Aljenedil, Sumayah
    Sadri, Iman
    de Varennes, Emilie
    Hegele, Robert A.
    Couture, Patrick
    Bergeron, Jean
    Wanneh, Eric
    Baass, Alexis
    Dufour, Robert
    Gaudet, Daniel
    Brisson, Diane
    Brunham, Liam R.
    Francis, Gordon A.
    Cermakova, Lubomira
    Brophy, James M.
    Ryomoto, Arnold
    Mancini, G. B. John
    Genest, Jacques
    [J]. CLINICAL CHEMISTRY, 2018, 64 (02) : 355 - 362
  • [47] LDL-cholesterol goal attainment among patients with diabetes mellitus treated with ezetimibe plus simvastatin coadministration versus simvastatin alone
    McKenney, J
    Insull, W
    Lewin, A
    Lee, M
    Kush, D
    Mitchel, Y
    [J]. DIABETES, 2004, 53 : A231 - A231
  • [48] Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients
    Coll, Blai
    Aragones, Gerard
    Parra, Sandra
    Alonso-Villaverde, Carlos
    Masana, Lluis
    [J]. AIDS, 2006, 20 (12) : 1675 - 1677
  • [49] Atorvastatin therapy for treatment of severe hypercholesterolemia in patients undergoing regular LDL-apheresis
    Sinzinger, H
    Granegger, S
    Ferlitsch, A
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 61 - 61
  • [50] Ezetimibe effectively lowers LDL cholesterol in cardiac allograft recipients on stable statin therapy
    Konstandin, M. H.
    Celik, S.
    Dosch, A.
    Koch, A.
    Sack, F. U.
    Katus, H. A.
    Dengler, T. J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S226 - S226
12345